Drug resistance of infectious pathogens after liver transplantation

Jian-Dang Zhou1, Jian-Jun Guo, Qin Zhang

  • 1Department of Clinical Laboratory, the Third Xiangya Hospital of Central South University, Changsha 410013, China. jiandangzhou@126.com

Abstract

Insights

Infections in liver transplant recipients are often caused by drug-resistant bacteria, particularly Gram-negative strains producing extended-spectrum beta-lactamases (ESBLs) and AmpC beta-lactamases. Enterococcal infections also pose a significant challenge.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Transplantation

Background:

  • Infections significantly increase the risk of graft failure and mortality in liver transplant recipients.
  • Understanding the spectrum of infectious agents is crucial for optimizing anti-infective therapies.

Purpose of the Study:

  • To characterize infectious pathogens and their antimicrobial resistance patterns in liver transplant recipients.
  • To identify key resistance mechanisms contributing to treatment challenges.

Main Methods:

  • Pathogen isolation from clinical specimens of liver recipients.
  • Antimicrobial susceptibility testing using the K-B method.
  • Detection of specific resistance genes, including extended-spectrum beta-lactamase (ESBL), AmpC beta-lactamase, and vancomycin resistance genes in Gram-negative bacteria and enterococci.

Main Results:

  • 39 out of 55 recipients experienced infections, with 513 bacterial strains isolated.
  • Predominantly Gram-negative bacteria were identified, with over 40% exhibiting multi-drug resistance (resistance to >4 drugs).
  • High rates of ESBL and AmpC beta-lactamase production were observed in E. cloacae and E. coli; vancomycin resistance was noted in Enterococcus faecalis and E. faecium.

Conclusions:

  • Infectious pathogens in liver transplant recipients are frequently potent and multi-drug resistant.
  • ESBLs and AmpC beta-lactamases are primary drivers of Gram-negative bacterial resistance.
  • Enterococcal infections represent a significant and challenging aspect of post-transplant infections.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...